44LOW

CYC

CYCLOPHARM FPO [CYC]
Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, the United States, and internationally. The company operates Technegas which offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism and other respiratory conditions. It is also involved in the research and development; and distribution of third-party products to the diagnostic imaging sector. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.
Healthcare · ASX Small Cap
$0.7920 -1.0%

Updated 26 Mar 2026 · Scores refresh every scan

Score Breakdown

Technical59
Catalyst55
Sentiment50
Fundamental55
Momentum39
Risk Gate50
Get alerts when CYC's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Track CYC — Free

Active Signals

Bullish Signals

  • MACD momentum is picking up steam
  • Volume surging at 2.0x normal while price climbs — real buying conviction behind this move
  • Watch out — volume is flowing out even as price holds up. Distribution pattern
  • Critical cash runway (1.5 quarters)
  • Low P/S ratio (2.9x)
  • Moderate revenue growth (+18%)
  • EPS estimates revised upward (+10pts)
  • Small-cap ($20-100M)
  • CANSLIM I: Institutional ownership (26%)
  • Sentiment is mixed — no strong consensus either way
  • RBA hiking (-3pts)

Risk Signals

  • Below the 200-day average — the long-term trend is still working against it
  • Deeply negative margins (-53%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Long-term momentum is negative — down 30% over the past year
  • The bigger volume days are the down days — volume-weighted momentum is negative (-1.29%/day)
  • Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about CYC
"What's driving CYC's score?" "How does CYC compare to peers?" "Key risks for CYC?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE CYC Secures Multi-Site Agreement with Northwestern Medicine
NONE CYC Signs Enterprise Agreement with UPHS
NONE Change of Director's Interest Notice - KB
Announcement tone +5pts

Recent ASX Announcements

2026-03-23 CYC Secures Multi-Site Agreement with Northwestern Medicine PRICE SENSITIVE
2026-03-22 CYC Signs Enterprise Agreement with UPHS PRICE SENSITIVE
2026-03-12 Change of Director's Interest Notice - KB
2026-03-12 Change of Director's Interest Notice - JW
2026-03-12 Change of Director's Interest Notice - DA

Key Metrics

$94.2M
Market Cap
97K
Avg Volume
2.0x
Vol Ratio
$0.56 — $1.48
52-Week Range
0.0%
Short Interest
N/A
Cash Runway
-49.3%
ROE
-53.3%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 50%
LLeader vs LaggardlaggardRS: -4
IInstitutional SponsorshippassInst: 26%
MMarket DirectionneutralNeutral

Sector: Healthcare

Ranked #77 of 117 · Sector avg: 46

View all Healthcare signals →
Related Tickers
ATX 59PNV 56IMM 55EYE 55AHC 55
Compare:CYC vs ATXCYC vs PNVCYC vs IMM
Scout Pro — Deeper Analysis for CYC
Try Pro free for 30 days
Share this analysis

Track CYC and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required